ABBOTT ULTANE INHALATION ANESTHETIC SHIPMENTS TO BEGIN BY END OF JUNE; PHASE IV NEPHROTOXICITY STUDIES TO FOCUS ON COMPOUND A, LOW GAS FLOW RATES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".